Inovio Pharmaceuticals INO
NASDAQ INO
$1.16 -0.05 (-4.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Inovio Pharmaceuticals' Net Equity Issued and Repurchased came in at $12.88 million for Q2 2026.

Analysis

Inovio Pharmaceuticals (INO) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Inovio Pharmaceuticals reported Net Equity Issued and Repurchased of $47.77 million, up 221.7% year-over-year; for FY2025, it was $34.91 million, down 3.1% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -40.1% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $36.03 million in FY2024 (+559.7%), $5.46 million in FY2023 (-93.4%), $82.96 million in FY2022 (-60.4%) and $209.44 million in FY2021 (-53.9%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is $667,066 (Q3 2024) to $47.34 million (Q4 2021).
  • Year-over-year, Net Equity Issued and Repurchased increased in three of the last six quarters, with growth averaging 267.6%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q3 2025 (growth of 977.1%), and the weakest in Q2 2023 (a decline of 93.2%).
  • Business Quant data shows INO's Net Equity Issued and Repurchased at $1.08 million (Q1 2026), $26.62 million (Q4 2025) and $7.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Inovio Pharmaceuticals 98.76 Mn 98.76 Mn - 12.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.88 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 26.62 Mn
Sep 30, 2025 7.19 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 13.08 Mn
Sep 30, 2024 667,066.00
Jun 30, 2024 17.06 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 1.84 Mn
Sep 30, 2023 708,283.00
Jun 30, 2023 2.92 Mn
Dec 31, 2022 6.67 Mn
Sep 30, 2022 3.77 Mn
Jun 30, 2022 43.16 Mn
Mar 31, 2022 29.36 Mn
Dec 31, 2021 47.34 Mn
Mar 31, 2021 162.11 Mn
Dec 31, 2020 124.53 Mn
Jun 30, 2020 121.72 Mn
API Access

Inovio Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INO&period=max&api_key=YOUR_API_KEY